Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Applied Cell Technology

Applied Cell Technology
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$528K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer and distributor of patented platform technology created to enhance cell competence. The company's patented platform technology form genetic materials to preconditioning stallion semen improves the effectiveness of cryopreservation by preserving viability and function of the spermatozoa, makes zebrafish embryos capable to survive chilled storage for 24 hours, enhances the recovery rate of motile human sperm cells after cryopreservation, enables significantly better survival of stem cells, gametes, embryos after interventions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1 Búza street
  • Gyöngyös, 3200
  • Hungary

+36 (1) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Applied Cell Technology’s full profile, request a free trial.

Applied Cell Technology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 31-Dec-2015 $528K Completed Startup
2. Early Stage VC Completed Startup
1. Early Stage VC 01-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Applied Cell Technology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Research, Development and Innovation Office Government 000 0000 000000 0
Széchenyi Equity Fund Manager Venture Capital Minority 000 0000 000000 0
PortfoLion Corporate Venture Capital Minority 000 0000 000000 0

Applied Cell Technology Executive Team (3)

Name Title Board
Seat
Contact
Info
Akos Toth Chief Marketing Officer & Chief Technology Officer
Gábor Juhász General Manager
Judit Cserepes Ph.D Chief Scientific Officer